Al-Dulaimi, A., Saadallah, M., Ali, Z. (2025). Solid Lipid Nanoparticles as Innovative Carriers in Drug Delivery: A Review. , 22(3), 133-148. doi: 10.33899/iraqij.p.2025.159351.1140
Amal Fakhruldeen Al-Dulaimi; Mais Salim Saadallah; Zahraa Hussein Ali. "Solid Lipid Nanoparticles as Innovative Carriers in Drug Delivery: A Review". , 22, 3, 2025, 133-148. doi: 10.33899/iraqij.p.2025.159351.1140
Al-Dulaimi, A., Saadallah, M., Ali, Z. (2025). 'Solid Lipid Nanoparticles as Innovative Carriers in Drug Delivery: A Review', , 22(3), pp. 133-148. doi: 10.33899/iraqij.p.2025.159351.1140
Al-Dulaimi, A., Saadallah, M., Ali, Z. Solid Lipid Nanoparticles as Innovative Carriers in Drug Delivery: A Review. , 2025; 22(3): 133-148. doi: 10.33899/iraqij.p.2025.159351.1140

Solid Lipid Nanoparticles as Innovative Carriers in Drug Delivery: A Review

Iraqi Journal of Pharmacy
Article 3, Volume 22, Issue 3, September 2025, Pages 133-148    PDF (1009.46 K)
Document Type: Review Paper
DOI: 10.33899/iraqij.p.2025.159351.1140
Authors
Amal Fakhruldeen Al-Dulaimi* 1; Mais Salim Saadallah2; Zahraa Hussein Ali2
1Department of Pharmaceutical Chemistry, College of Pharmacy, University of Mosul, Mosul, Iraq
2Department of Pharmaceutics, College of Pharmacy, University of Mosul, Mosul, Iraq
Abstract
Background: Nanoparticle technology is a new drug delivery system with nano-scale-size. The solid lipid nanoparticles are dynamic systems adopted for formulating water-soluble and insoluble drugs in a colloidal carrier. Their matrix is solid lipids at room temperature and their size ranges from 10 - 1000 nm. Solid lipid nanoparticles have many privileges including protection of drugs from chemical, photochemical, and oxidative degradation. Also, they could be modified to be formulated as sustained-release or controlled-release dosage forms. Their limitations involve the low drug loading capacity with the possibility of leakage and damage during storage. The components of solid lipid nanoparticles are different but generally regarded as safe. Their preparation methods are numerous, ranging from the usual high-pressure homogenization to the green strategies. The most important applications of solid lipid nanoparticles include parasitic infection, cancers and brain diseases. The bioavailability and efficacy of drugs like praziquantel, nitazoxanide, and amphotericin B were greatly enhanced by solid lipid nanoparticles, improving treatment outcomes for conditions such as Leishmaniasis, toxoplasmosis, and schistosomiasis. In cancer therapy, solid lipid nanoparticles have been employed to target breast, lung, liver, and colon cancers, offering improved cellular uptake, increased cytotoxicity, and reduced systemic toxicity through surface decoration approaches. Furthermore, by overcoming the blood-brain barrier, solid lipid nanoparticles have shown a trustworthy promise in facilitating effective brain delivery of therapeutics for neurodegenerative disorders and brain tumors. Aim: This review highlights the solid lipid nanoparticles' privileges, limitations, components, preparation techniques and their most important applications. Conclusion: solid lipid nanoparticles applications in parasitic infection, cancers and brain disease could overcome the traditional drug delivery challenges. By reducing systemic toxicity, enhancing bioavailability, and improving targeting, they pave the way for more effective therapies.

Highlights
  1. Solid lipid nanoparticles (SLNs) enhance bioavailability and reduce drug toxicity.
  2. SLNs face challenges like low drug loading and long-term stability.
  3. Preparation methods include green techniques with improved safety and efficiency.
  4. SLNs offer targeted delivery for parasitic, cancer, and brain diseases.
  5. Surface modifications boost SLNs' therapeutic index and targeting ability.
Keywords
Solid lipid nanoparticles; Green strategies; Cancer therapy; Parasitic infection; Brain delivery
References
  1. Prabhakar P, Banerjee M. Nanotechnology in drug delivery system: Challenges and opportunities. Journal of Pharmaceutical Sciences and Research 2020;12(4):492–8.
  2. Teleanu DM, Chircov C, Grumezescu AM, Teleanu RI. Neuronanomedicine: An up-to-date overview. Pharmaceutics 2019;11(3):1–23.
  3. Hashida M. Role of pharmacokinetic consideration for the development of drug delivery systems: A historical overview. Advanced drug delivery reviews 2020;157:71–82.
  4. Saadallah M, Hamid O. Strategies to enhance transdermal drug delivery. Iraqi Journal of Pharmacy 2021;18(1):78–92.
  5. Hamid OA, Albazzaz FY, Dhahir RK. Formulation and characterization of chitosan nanoparticles to enhance transdermal delivery of cinnarizine. International Journal of Pharmaceutical Excipients 2023;14(3):71–84.
  6. Saadallah MS, Hamid OA. Eudragit® L100 nanoparticles for transdermal delivery of rosuvastatin calcium. Journal of Excipients & Food Chemicals 2022;13(3).
  7. Chen Q, Yang Z, Liu H, Man J, Oladejo AO, Ibrahim S, et al. Novel drug delivery systems: An important direction for drug innovation research and development. Pharmaceutics 2024;16(5): 674.
  8. Al-Dulaimi AF, Al-Kotaji M, Abachi FT. Development of novel paracetamol/naproxen co-crystals for improvement in naproxen solubility. Iraqi Journal of Pharmaceutical Sciences 2022;31(1):202–19.
  9. Ali ZH, Alkotaji M. Nanoemulsion-based nasal in situ gel of olanzapine. International Journal of Pharmaceutical Excipients 2023;14(1):3–21.
  10. Saadallah MS, Ali ZH, Al-dulaimi AF. The applications of dissolving microneedles in vaccine delivery and cancer therapy over the last decade : A review. International Journal of Pharmacy and Pharmaceutical Studies 2022;6(4):08–35.
  11. Ali ZH, Alkotaji M. Smart hydrogel polymers for drug delivery. Military Medical Science Letters (Vojenske Zdravotnicke Listy) 2022;91(2):105–18.
  12. Shrestha S, Wang B, Dutta P. Nanoparticle processing: Understanding and controlling aggregation. Advances in colloid and interface science 2020;1;279:102162.
  13. Saadallah MS, Hamid OA. Formulation and evaluation of rosuvastatin calcium polymeric nanoparticles-loaded transdermal patch. Iraqi Journal of Pharmacy 2022;18(2):22–38.
  14. Ealias SA, Saravanakumar MP. A review on the classification, characterisation, synthesis of nanoparticles and their application. In IOP conference series: materials science and engineering 2017;263(3):032019.
  15. Yetisgin AA, Cetinel S, Zuvin M, Kosar A, Kutlu O. Therapeutic nanoparticles and their targeted delivery applications. Molecules 2020;25(9):2193.
  16. Madkhali OA. Perspectives and prospective on solid lipid nanoparticles as drug delivery systems. Molecules 2022;27(5):1543.
  17. Scioli Montoto S, Muraca G, Ruiz ME. Solid lipid nanoparticles for drug delivery: Pharmacological and biopharmaceutical aspects. Frontiers in molecular biosciences 2020; 30;7:587997.
  18. Kamarehei F. The effects of combination therapy by solid lipid nanoparticle and dental stem cells on different degenerative diseases. American Journal of Translational Research 2022;14(5):3327.
  19. Duan Y, Dhar A, Patel C, Khimani M, Neogi S, Sharma P, et al. A brief review on solid lipid nanoparticles: Part and parcel of contemporary drug delivery systems. Royal Society of Chemistry Advances 2020;10(45):26777–91.
  20. Afzal O, Altamimi AS, Nadeem MS, Alzarea SI, Almalki WH, Tariq A, et al. Nanoparticles in drug delivery: From history to therapeutic applications. Nanomaterials 2022;12(24): 4494.
  21. Al-Dulaimi AF, Al-kotaji M, Abachi FT. Co-Crystals for improving solubility and bioavailability of pharmaceutical products. Egyptian Journal of Chemistry 2022;65(1):81–9.
  22. Mirchandani Y, Patravale VB, Brijesh S. Solid lipid nanoparticles for hydrophilic drugs. Journal of controlled release 2021;10;335:457-64.
  23. Soltani A, Pakravan P. Preparation and characterization of magnetic solid lipid nanoparticles as a targeted drug delivery system for doxorubicin. Advanced pharmaceutical bulletin 2023;13(2):301–8.
  24. Üner M, Yener G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspective. International journal of nanomedicine 2007;2(3):289–300.
  25. Yadav N, Khatak S, Singh Sara UV. Solid lipid nanoparticles- A review. International Journal of Applied Pharmaceutics 2013;5(2):8–18.
  26. Reddy SH, Umashankar MS, Damodharan N. Formulation, characterization and applications on solid lipid nanoparticles–a review. Research Journal of Pharmacy and Technology 2018;11(12):5691-700.
  27. Akbari J, Saeedi M, Ahmadi F, Hashemi SMH, Babaei A, Yaddollahi S, et al. Solid lipid nanoparticles and nanostructured lipid carriers: A review of the methods of manufacture and routes of administration. Pharmaceutical development and technology 2022;27(5):525–44.
  28. Chutoprapat R, Kopongpanich P, Chan LW. A mini-review on solid lipid nanoparticles and nanostructured lipid carriers: Topical delivery of phytochemicals for the treatment of acne vulgaris. Molecules 2022;27(11):3460.
  29. Munir M, Zaman M, Waqar MA, Khan MA, Alvi MN. Solid lipid nanoparticles: A versatile approach for controlled release and targeted drug delivery. Journal of liposome research 2024;34(2):335–48.
  30. Satapathy MK, Yen TL, Jan JS, Tang RD, Wang JY, Taliyan R, et al. Solid lipid nanoparticles (Slns): An advanced drug delivery system targeting brain through BBB. Pharmaceutics 2021;13(8): 1183.
  31. Pandey S, Shaikh F, Gupta A, Tripathi P, Yadav JS. A recent update: Solid lipid nanoparticles for effective drug delivery. Advanced Pharmaceutical Bulletin 2022;12(1):17–33.
  32. Musielak E, Feliczak-Guzik A, Nowak I. Synthesis and potential applications of lipid nanoparticles in medicine. Materials 2022;15(2):682.
  33. Kaushik L, Srivastava S, Panjeta A, Chaudhari D, Ghadi R, Kuche K, et al. Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance. International Journal of Pharmaceutics 2020;578:119088.
  34. Patel R. Fatty acid-based solid lipid nanoparticles and their effects on metabolism and permeability of drugs [Ph.D. dissertation]. London: Kingston University at London; 2023. 38 p.
  35. Mokhtar HI, Khodeer DM, Alzahrani S, Qushawy M, Alshaman R, Elsherbiny NM, et al. Formulation and characterization of cholesterol-based nanoparticles of gabapentin protecting from retinal injury. Frontiers in Chemistry 2024;12:1449380.
  36. Shakeri M, Ghobadi R, Sohrabvandi S, Khanniri E, Mollakhalili-Meybodi N. Co-encapsulation of omega-3 and vitamin D3 in beeswax solid lipid nanoparticles to evaluate physicochemical and in vitro release properties. Frontiers in Nutrition 2024;11:1323067.
  37. Mohammed HA, Khan RA, Singh V, Yusuf M, Akhtar N, Sulaiman GM, et al. Solid lipid nanoparticles for targeted natural and synthetic drugs delivery in high-incidence cancers, and other diseases: Roles of preparation methods, lipid composition, transitional stability, and release profiles in nanocarriers’ development. Nanotechnology Reviews 2023;12(1):20220517.
  38. Madureira AR, Nunes S, Campos DA, Fernandes JC, Marques C, Zuzarte M, et al. Safety profile of solid lipid nanoparticles loaded with rosmarinic acid for oral use: In vitro and animal approaches. International journal of nanomedicine 2016;3621–40.
  39. Zabihi M, Shafaei M, Ramezani V, Dara T, Mirzaie F. Preparation of thymol nanoliposome and solid lipid nanoparticle and evaluation of their inhibitory effects on leishmania major promastigotes. Advances in Pharmacology and Therapeutics Journal 2023;3(1):49–60.
  40. Sathyamoorthy N, Sundar VD, Rajendran V, Sirikonda N, Narayanaswamy H. Utility of different lipids and effect of soya lecithin on sustained delivery of zidovudine via biodegradable solid lipid microparticles: Formulation and in-vitro characterization. Indian Journal of Pharmaceutical Education and Research 2022;56(3):689–96.
  41. Aldayel TS, Badran MM, Alomrani AH, AlFaris NA, Altamimi JZ, Alqahtani AS, et al. Optimization of cationic nanoparticles stabilized by poloxamer 188: A potential approach for improving the biological activity of Aloe perryi. Heliyon 2023;9(12).
  42. Khaleseh F, Barzegar-Jalali M, Zakeri-Milani P, Islambulchilar Z, Valizadeh H. Optimum surfactant concentration for preparation of amiodarone loaded solid lipid nanoparticles: Theoretical estimation versus experimental results by box-behnken design. Journal of Reports in Pharmaceutical Sciences 2024;12(1):1–15.
  43. Saka OM, Aygüler C rem, Özdemir NS, Sürücü B, Çakırlı E, Nemutlu E, et al. An Experimental Design Approach for Producing Curcumin-Loaded Solid Lipid Nanoparticles. Pharmaceuticals 2025;18(4):470.
  44. Mishra SK, Bhardwaj P, Tripathi A, Gupta R, Dudhe R, Patil P, et al. Development and characterization of solid lipid nanoparticles of aceclofenac by microemulsion technique using lecithin, pleuronic F-68, and sodium glycocholate. Journal of Advanced Scientific Research 2020;11(3):207–12.
  45. Santonocito D, Sarpietro MG, Castelli F, Lauro MR, Torrisi C, Russo S, et al. Development of solid lipid nanoparticles as dry powder: characterization and formulation considerations. Molecules 2023;28(4):1545.
  46. Chandira RM, Pethappachetty P, Lakhshmanan G, Samy DA. Design and evaluation of solid lipid nanoparticles of an antibiotic-mannitol as cryoprotectant. Asian Journal of Biological and Life Sciences 2022;11(2):380–8.
  47. Bhattacharya S, Sharma S. Dacarbazine-encapsulated solid lipid nanoparticles for skin cancer: physical characterization, stability, in-vivo activity, histopathology, and immunohistochemistry. Frontiers in Oncology 2023;13(April):1102269.
  48. Gupta N, Shukla VK. Surface modification of solid lipid nanoparticles: Enhancements in drug delivery and treatment efficacy. Current Nanomedicine 2025.
  49. Mondéjar-López M, López-Jimenez AJ, Martínez JCG, Ahrazem O, Gómez-Gómez L, Niza E. Comparative evaluation of carvacrol and eugenol chitosan nanoparticles as eco-friendly preservative agents in cosmetics. International journal of biological macromolecules 2022;206:288–97.
  50. Lüdtke FL, Silva TJ, da Silva MG, Hashimoto JC, Ribeiro APB. Lipid nanoparticles: Formulation, production methods and characterization protocols. Foods 2025;14(6):973.
  51. Monsef AS, Nemattalab M, Parvinroo S, Hesari Z. Antibacterial effects of thyme oil loaded solid lipid and chitosan nano-carriers against Salmonella Typhimurium and Escherichia coli as food preservatives. PLoS one 2024;19(12): e0315543.
  52. Singh AK, Mukerjee A, Pandey H, Mishra SB. Fabrication of solid lipid nanoparticles by hot high shear homogenization and optimization by Box—Behnken design: An accelerated stability assessment. Journal of Applied Pharmaceutical Science 2021;11(9):035–47.
  53. Gupta S, Kesarla R, Chotai N, Misra A, Omri A. Systematic approach for the formulation and optimization of solid lipid nanoparticles of efavirenz by high pressure homogenization using design of experiments for brain targeting and enhanced bioavailability. Biomed research international 2017;2017 (1):5984014.
  54. López KL, Ravasio A, González-Aramundiz JV, Zacconi FC. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) prepared by microwave and ultrasound-assisted synthesis: promising green strategies for the nanoworld. Pharmaceutics 2023;15(5):1333.
  55. Panigrahi D, Sahu PK, Swain S, Verma RK. Quality by design prospects of pharmaceuticals application of double emulsion method for PLGA loaded nanoparticles. SN applied sciences 2021;3(6):1-21.
  56. Ghasemiyeh P, Mohammadi-Samani S. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: Applications, advantages and disadvantages. Research in pharmaceutical sciences 2018;13(4):288–303.
  57. Rehman M, Rahman A, Islam Z, Khan N, Nazir A, Saeed A. Fabrication of sulfasalazine-loaded solid lipid nanoparticles through solvent emulsification diffusion technique : Pharmaceutical and stability studies. Indus Journal of Bioscience Research 2025;3(1):647–56.
  58. Mehmood Y, Shahid H, Rizvi SM, Jamshaid U, Arshad N, Nur-e-Alam M, et al. Hyaluronic acid-solid lipid nano transporter serum preparation for enhancing topical tretinoin delivery: skin safety study and visual assessment of skin. Frontiers in Pharmacology 2024;15:1401594.
  59. Puri D, Mishra A, Singh AP, Gaur PK, Singh M, Yasir M. Formulation development of topical preparation containing nanoparticles of povidone-iodine for wound healing. ASSAY and Drug Development Technologies 2021;19(2):115–23.
  60. Duong VA, Nguyen TTL, Maeng HJ. Preparation of solid lipid nanoparticles and nanostructured lipid carriers for drug delivery and the effects of preparation parameters of solvent injection method. Molecules 2020;25(20):4781.
  61. Fadda P, Monduzzi M, Caboi F, Piras S, Lazzari P. Solid lipid nanoparticle preparation by a warm microemulsion based process: Influence of microemulsion microstructure. International journal of pharmaceutics 2013;446(1–2):166–75.
  62. Itsarasook K, Prompamorn P, Modsuwan S, Tanghiranrat J, Komutiban O, Haritakun W, et al. Preparation, characterization and evaluation of octyl methoxycinnamate (OMC)-loaded solid lipid nanoparticles (SLNs) by using a microemulsion technique. Journal of Food Health and Bioenvironmental Science 2022;15(1):57–64.
  63. Kolapkar JS. Exploring innovative approaches for the preparation of solid lipid nanoparticles: Advancements in drugs delivery for modern medicin. Intentional Journal of Science Academic Research 2024;05(11):8654–62.
  64. Karimi M, Raofie F, Karimi M. Production Ganoderma lucidum extract nanoparticles by expansion of supercritical fluid solution and evaluation of the antioxidant ability. Scientific reports 2022;12(1): 9904.
  65. Alajami HN, Fouad EA, Ashour AE, Kumar A, Yassin AEB. Celecoxib-loaded solid lipid nanoparticles for colon delivery: formulation optimization and in vitro assessment of anti-cancer activity. Pharmaceutics 2022;14(1):131.
  66. Pucek-kaczmarek A. Influence of process design on the preparation of solid lipid nanoparticles by an ultrasonic-nanoemulsification method. Processes 2021;9(8):1265.
  67. Qushawy M, Nasr A. Solid lipid nanoparticles (SLNs) as nano drug delivery carriers: Preparation, characterization and application. International Journal of Applied Pharmaceutics 2020;12(1):1–9.
  68. Aldawsari HM, Singh S. Rapid microwave-assisted cisplatin-loaded solid lipid nanoparticles: Synthesis, characterization and anticancer study. Nanomaterials 2020;10(3):510.
  69. Sharma M, Mundlia J, Kumar T, Ahuja M. A novel microwave-assisted synthesis, characterization and evaluation of luliconazole-loaded solid lipid nanoparticles. Polymer Bulletin 2021;78(5):2553–67.
  70. Shah RM, Eldridge DS, Palombo EA, Harding IH. Microwave-assisted formulation of solid lipid nanoparticles loaded with non-steroidal anti-inflammatory drugs. International journal of pharmaceutics 2016;515(1–2):543–54.
  71. Trucillo P, Campardelli R. Production of solid lipid nanoparticles with a supercritical fluid assisted process. The Journal of Supercritical Fluids 2019;1(143):16–23.
  72. Park H, Kim JS, Kim S, Ha ES, Kim MS, Hwang SJ. Pharmaceutical applications of supercritical fluid extraction of emulsions for micro-/nanoparticle formation. Pharmaceutics 2021;13(11):1928.
  73. Ramadon D. Solid lipid nanoparticles (SLN): Formulation and fabrication. Pharmaceutical Sciences and Research (PSR) 2023;10(2):55-66.
  74. Subroto E, Andoyo R, Indiarto R. Solid lipid nanoparticles: Review of the current research on encapsulation and delivery systems for active and antioxidant compounds. Antioxidants 2023;12(3):633.
  75. Barroso L, Viegas C, Vieira J, Ferreira-Pêgo C, Costa J, Fonte P. Lipid-based carriers for food ingredients delivery. Journal of Food Engineering 2021;295:110451.
  76. Alsaad AAA, Hussien AA, Gareeb MM. Solid lipid nanoparticles (SLN) as a novel drug delivery system: A theoretical review. Systematic Review Pharmacy 2020;11(5):259–73.
  77. Akbari Z, Amanlou M, Karimi-Sabet J, Golestani A, Niassar MS. Application of supercritical fluid technology for preparation of drug loaded solid lipid nanoparticles. . International journal of nanoscience and nanotechnology 2020;16(1):13–33.
  78. Aldayel TS, M. Badran M, H. Alomrani A, AlFaris NA, Z. Altamimi J, S. Alqahtani A, et al. Chitosan-coated solid lipid nanoparticles as an efficient avenue for boosted biological activities of aloe perryi: antioxidant, antibacterial, and anticancer potential. Molecules 2023;28(8):3569.
  79. Dunn MA. Parasitic Diseases. In: Eugene R. Schiff, Willis C. Maddrey, K Rajender Reddy, editors. Schiff’s disease of the liver. London: Wiley; 2017.1013–1027p.
  80. Escrivani DO, Mattos GC, Rossi-Bergmann B, Sousa-Batista AJ. Nano and microstructured delivery systems for current antileishmanial drugs. In: Vermelho AB, Supuran CT, editors. Antiprotozoal drug development and delivery. Cham: Springer International Publishing; 2022. 181–217p.
  81. Parvez S, Yadagiri G, Gedda MR, Singh A, Singh OP, Verma A, et al. Modified solid lipid nanoparticles encapsulated with amphotericin B and paromomycin: An effective oral combination against experimental murine visceral leishmaniasis. Scientific Reports 2020;10(1):12243.
  82. Sen R, Ganguly S, Saha P, Chatterjee M. Efficacy of artemisinin in experimental visceral leishmaniasis. International Journal of Antimicrobial Agents 2010;36(1):43–9.
  83. Akbari M, Heli H, Oryan A, Hatam G. A novel outlook in the delivery of artemisinin: production and efficacy in experimental visceral leishmaniasis. Pathogens and Global Health 2024;118(1):40–6.
  84. Aguirre AA, Longcore T, Barbieri M, Dabritz H, Hill D, Klein PN, et al. The one health approach to toxoplasmosis: epidemiology, control, and prevention strategies. EcoHealth 2019;16(2):378–90.
  85. Kappagoda S, Singh U, Blackburn BG. Antiparasitic therapy. Mayo Clinic Proceedings 2011;86(6):561–83.
  86. Ghadiri M, Fatemi S, Vatanara A, Doroud D, Najafabadi AR, Darabi M, et al. Loading hydrophilic drug in solid lipid media as nanoparticles: Statistical modeling of entrapment efficiency and particle size. International journal of pharmaceutics 2012;424(1–2):128–37.
  87. Khosravi M, Mohammad Rahimi H, Doroud D, Mirsamadi ES, Mirjalali H, Zali MR. In vitro evaluation of mannosylated paromomycin-loaded solid lipid nanoparticles on acute toxoplasmosis. Frontiers in cellular and infection microbiology 2020;10:33.
  88. Sharma S, Goel V, Kaur P, Gadhave K, Garg N, Singla L Das, et al. Targeted drug delivery using beeswax-derived albendazole-loaded solid lipid nanoparticles in Haemonchus contortus, an albendazole-tolerant nematode. Experimental Parasitology 2023;253:108593.
  89. Alade T, Ta-Tang T-H, Nassar SA, Akindele AA, Capote-Morales R, Omobami TB, et al. Prevalence of schistosoma haematobium and intestinal helminth infections among Nigerian school children. Diagnostics 2023 Feb;13(4):759.
  90. Raghavan R. Expanding the frontiers of schistosomiasis treatment: The promise of nanoparticle based therapies. OSF preprints 2023.
  91. Adekiya TA, Kumar P, Kondiah PPD, Ubanako P, Choonara YE. In vivo evaluation of praziquantel-loaded solid lipid nanoparticles against S. mansoni infection in preclinical murine models. International Journal of Molecular Sciences 2022;23(16):9485.
  92. Manjunath K, Reddy JS, Venkateswarlu V. Solid lipid nanoparticles as drug delivery systems. Methods and Findings in Experimental and Clinical Pharmacology 2005;27(2):127–44.
  93. Ramteke KH, Joshi SA, Dhole SN. Solid lipid nanoparticle: A review. IOSR journal of pharmacy 2012;2(6):34–44.
  94. Bhagwat GS, Athawale RB, Gude RP, Md S, Alhakamy NA, Fahmy UA, et al. Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy. Frontiers in pharmacology 2020;11:614290.
  95. Ozgenc E, Karpuz M, Arzuk E, Gonzalez-Alvarez M, Sanz MB, Gundogdu E, et al. Radiolabeled trastuzumab solid lipid nanoparticles for breast cancer cell: in vitro and in vivo studies. American Chemical Society omega 2022;7(34):30015–27.
  96. Darabi F, Saidijam M, Nouri F, Mahjub R, Soleimani M. Anti‐CD44 and EGFR dual‐targeted solid lipid nanoparticles for delivery of doxorubicin to triple‐negative breast cancer cell line: Preparation, statistical optimization, and in vitro characterization. BioMed Research International 2022;2022(1):6253978.
  97. Afarin R, Ahmadpour F, Hatami M, Monjezi S, Igder S. Combination of Etoposide and quercetin-loaded solid lipid nanoparticles Potentiates apoptotic effects on MDA-MB-231 breast cancer cells. Heliyon 2024;10(11).
  98. Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A. Epidemiology of lung cancer. Contemporary Oncology/Współczesna Onkologia 2021;25(1):45–52.
  99. Abdul-Ghafar J, Oh SS, Park S-M, Wairagu P, Lee SN, Jeong Y, et al. Expression of adiponectin receptor 1 is indicative of favorable prognosis in non-small cell lung carcinoma. The Tohoku Journal of Experimental Medicine 2013;229(2):153–62.
  100. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer research 2003;23(1/A):363–98.
  101. Rahman MA, Ali A, Rahamathulla M, Salam S, Hani U, Wahab S, et al. Fabrication of sustained release curcumin-loaded solid lipid nanoparticles (cur-SLNs) as a potential drug delivery system for the treatment of lung cancer: Optimization of formulation and in vitro biological evaluation. Polymers 2023;15(3):542.
  102. Li M, Fang G, Zahid F, Saleem R, Ishrat G, Ali Z, et al. Co-delivery of paclitaxel and curcumin loaded solid lipid nanoparticles for improved targeting of lung cancer: In vitro and in vivo investigation. Heliyon 2024;10(9).
  103. Lawrence TS, Robertson JM, Anscher MS, Jirtle RL, Ensminger WD, Fajardo LF. Hepatic toxicity resulting from cancer treatment. International Journal of Radiation Oncology* Biology* Physics1995;31(5):1237–48.
  104. Raza A, Sood GK. Hepatocellular carcinoma review: current treatment, and evidence-based medicine. World journal of gastroenterology 2014;20(15):4115.
  105. Ergin AD, Oltulu Ç, Koç B. Enhanced cytotoxic activity of 6-Mercaptopurine–loaded solid lipid nanoparticles in hepatic cancer treatment. ASSAY and Drug Development Technologies 2023;21(5):212–21.
  106. Iacobazzi RM, Vischio F, Arduino I, Canepa F, Laquintana V, Notarnicola M, et al. Magnetic implants in vivo guiding sorafenib liver delivery by superparamagnetic solid lipid nanoparticles. Journal of Colloid and Interface Science 2022;608:239–54.
  107. Xu Y, Wang M, Ning S, Yang Z, Zhou L, Xia X. Development of glycyrrhetinic acid and folate modified cantharidin loaded solid lipid nanoparticles for targeting hepatocellular carcinoma. Molecules 2022;27(20):6786.
  108. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 2018;68(6):394–424.
  109. Kievit FM, Zhang M. Surface engineering of iron oxide nanoparticles for targeted cancer therapy. Accounts of chemical research 2011;44(10):853–62.
  110. Ahmed SS, Baba MZ, Wahedi U, Koppula J, Reddy MV, Selvaraj D, et al. Oral delivery of solid lipid nanoparticles surface decorated with hyaluronic acid and bovine serum albumin: A novel approach to treat colon cancer through active targeting. International Journal of Biological Macromolecules 2024;279:135487.
  111. Moghimipour E, Abedini M, Handali S. Targeted solid lipid nanoparticles formulation for colon Cancer treatment and cytotoxicity assessment using HT29 cell line. Jundishapur Journal of Natural Pharmaceutical Products 2023;18(2).
  112. Choonara YE, Pillay V, Du Toit LC, Modi G, Naidoo D, Ndesendo VMK, et al. Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders. International journal of molecular sciences 2009;10(6):2510–57.
  113. Patel M, Souto EB, Singh KK. Advances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticles. Expert opinion on drug delivery 2013;10(7):889–905.
  114. Saraiva C, Praça C, Ferreira R, Santos T, Ferreira L, Bernardino L. Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases. Journal of controlled release 2016;235:34–47.
  115. Khishvand MA, Yeganeh EM, Zarei M, Soleimani M, Mohammadi M, Mahjub R. Development, statistical optimization, and characterization of resveratrol‐containing solid lipid nanoparticles (SLNs) and determination of the efficacy in reducing neurodegenerative symptoms related to alzheimer’s disease: In vitro and in vivo study. BioMed Research International 2024;2024(1):7877265.
  116. Pinto BF, Silva GBRF da, Kraemer L, Santos GSP dos, Bèla SR, Leite F de L, et al. DMF-loaded SLN administrated by inhalation route attenuate clinical signs and reduce lung and CNS inflammation in MS animals’ model. 2021.
  117. Yasir M, Chauhan I, Zafar A, Verma M, Alruwaili NK, Noorulla KM, et al. Glyceryl behenate-based solid lipid nanoparticles as a carrier of haloperidol for nose to brain delivery: formulation development, in-vitro, and in-vivo evaluation. Brazilian Journal of Pharmaceutical Sciences 2023;58:e20254.
  118. Arduino I, Santoro A, De Santis S, Iacobazzi RM, Lopedota AA, Paradies E, et al. Microfluidic formulation of diazoxide-loaded solid lipid nanoparticles as a novel approach for Friedreich’s ataxia treatment. Journal of Drug Delivery Science and Technology 2024;97:105837.
  119. Das D. Current perspectives on glioblastoma treatment synergies between therapies and delivery systems. Asia-Pacific Journal Of Oncology 2024; 6: 1-8.
  120. Kadari A, Pooja D, Gora RH, Gudem S, Kolapalli VRM, Kulhari H, et al. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy. European Journal of Pharmaceutics and Biopharmaceutics 2018;132:168–79.
Statistics
Article View: 402
PDF Download: 230


Journal Management System. Powered by iJournalPro.com